Northeast Financial Consultants Inc Abbott Laboratories Transaction History

Northeast Financial Consultants Inc

$2.25 Billion
Q3 2024

A detailed history of Northeast Financial Consultants Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 6,381 shares of ABT stock, worth $739,557. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,381

Previous 6,326 0.87%

Holding current value

$739,557

Previous $657,000 10.65%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$100.07 - $118.13 $5,503 - $6,497	55 Added 0.87%	6,381 $727,000
Q2 2024 Aug 15, 2024	SELL	$100.73 - $112.44 $55,401 - $61,842	-550 Reduced 8.0%	6,326 $657,000
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $188,045 - $207,688	1,717 Added 33.28%	6,876 $781,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $4,585 - $5,501	48 Added 0.94%	5,159 $499,000
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $17,334 - $19,313	-172 Reduced 3.26%	5,111 $557,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $93,954 - $110,589	-970 Reduced 15.51%	5,283 $534,000
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $64,640 - $75,833	680 Added 12.2%	6,253 $686,000
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $59,894 - $69,346	-619 Reduced 10.0%	5,573 $539,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $23,782 - $28,745	-233 Reduced 3.63%	6,192 $673,000
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $30,899 - $37,679	271 Added 4.4%	6,425 $760,000
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $2,962 - $3,486	28 Added 0.46%	6,154 $713,000
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $86,527 - $101,942	795 Added 14.91%	6,126 $734,000
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $2,625 - $2,860	25 Added 0.47%	5,331 $584,000
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $1,374 - $1,669	15 Added 0.28%	5,306 $577,000
Q2 2020 Jul 30, 2020	SELL	$76.57 - $98.0 $313,937 - $401,800	-4,100 Reduced 43.66%	5,291 $484,000
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $1,193 - $1,745	19 Added 0.2%	9,391 $741,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $620,613 - $750,322	9,372 New	9,372 $749,000
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $224,674 - $254,523	-3,427 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $48,952 - $59,054	-805 Reduced 19.02%	3,427 $251,000
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $10,409 - $11,769	-185 Reduced 4.19%	4,232 $253,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $9,930 - $10,631	185 Added 4.37%	4,417 $252,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $203,389 - $227,004	4,232	4,232 $226,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Account

Northeast Financial Consultants Inc Abbott Laboratories Transaction History